Post by Dr. Till Giese

The era of "sustainability as compliance" is over. 💬 "In the years ahead, we will continue navigating the evolving regulatory and political landscape while working strategically with the industry towards harmonised standards." Tatiana Kalashnikova, Global ESG & Sustainability Lead at Merz Therapeutics. Tatiana's perspective reflects a powerful shift we've uncovered in our latest PwC Strategy& study: "Beyond Compliance: How Sustainability Can Power Pharma's Future." For years, sustainability in pharma has been treated as a reporting obligation. Today, it's emerging as a competitive advantage – reshaping supply chains, R&D, manufacturing, and investment decisions. Why now? Because the numbers tell a story that leaders can no longer ignore: ➡️ Nearly 9 out of 10 pharma leaders now place sustainability among their top strategic priorities ➡️ Only with shared industry standards (backed by 93% of leaders) will real progress be possible ➡️ AI and data transparency are becoming the new infrastructure of sustainable pharma – with 72% of operations leaders already relying on real-time insights ➡️ The biggest levers ahead: decarbonization and equitable access to medicines – each named a top priority by 71% of leaders So where should pharma leaders focus? Three shifts stand out: 🔸 From projects to strategy – sustainability must move out of CSR silos and into the boardroom, with capital allocation, KPIs, and leadership incentives reflecting its weight. 🔸 From opacity to intelligence – winning companies will turn fragmented supplier data into connected, AI-powered transparency across the full value chain. 🔸 From competition to coalition – no single player can decarbonize pharma alone. Industry-wide collaboration on standards, infrastructure, and circular models is the multiplier. The next decade will separate the pharma companies that report on sustainability from those that are powered by it. 🚀 📥 Discover the full study here: https://lnkd.in/eVxQQiqj Dr. Jens Neumann, Craig Stevenson, Anne Scheidt, Christelle Azar, Cindy Abt, Dr. Thomas Solbach, Fritz Heese, Christian Kaspar, Julian Offenhammer, Oliver R. Dolny, Dr. Sebastian Hölzl, Iryna (Stadnyk) Scheurlen, Fabian Ahrens, Jonathan Müller, Johannes Dizinger #Pharma #Sustainability #ESG #BeyondCompliance #Healthcare #Strategy

Video Content